3 misconceptions about the 2019 general election

Although the contest to enter Number 10 is in its infancy, there are already a number of dominant narratives beginning to take shape – and perhaps mistakenly so. 'Boris Johnson is heading for a majority' Despite Jeremy Corbyn stating that Labour have been ready for an election ever since the last, the party has long given the impression it is running scared of an...

Weak pound and economic uncertainty: an opportunity for US investors?

With uncertainty over Brexit continuing to hit investor confidence and the “Pound on a rollercoaster” in the currency markets, there has been a noticeable slowdown in deal volume in the domestic M&A market whilst people wait for a resolution...

Brexit makes understanding devolution in England more important than ever

Most discourse on Brexit and the future of the UK looks at how it could impact Scotland, Wales, and Northern Ireland. England is often overlooked in such analyses. Yet the UK's departure from the EU will have significant fiscal, policy, and political impacts for the largest, most populous UK nation. Devolution in England has been sporadic, to say the least. A total of 12 deals were agreed between government and regional authorities between 2014 and 2017 – but no further agreements have...

Europe and the supply of innovative medicines: why it matters

One of the standout features of the ‘no-deal’ Brexit debate has been the focus on the impact on supplies of medicines and medicinal products. This includes everything from chemical compounds and investigational medicinal products (IMPs) for clinical research through to short shelf-life medicines made on the continent. The debate has been a continuous battle between those outlining the possible impact on patients’ lives while struggling to quantify the extent of the impact. Some areas...

Private Equity investment in Pharma – why is the UK bucking the global trend?

In recent years we’ve become used to claims that the impasse of Brexit is drying up investment in UK life sciences. The argument also goes that global investment by pharmaceuticals in R&D – predicted to grow to $181 billion by 2022 – will instead flow to other countries. There is evidence that can support this theory but if you scrape below the surface and look at investment by private equity into life sciences the picture looks quite different. The figures actually suggest that...

logo
Joe Cormack 25th Sep, 2019 Insight
Brexit , Healthcare , Investment , pharma
5 min read

The lost parliament? Analysing the 2017-19 session

Depending on your politics, the Prime Minister’s decision to shut down parliament from the 9th September until the 14th October is either a coup d’etat to thwart opponents of a no-deal Brexit or a natural end to the most unusual and most unproductive parliamentary session in history. Long time coming What makes the 2017-19 session unusual is its length - typically, parliamentary sessions last for one year. This parliamentary session has now overtaken the 296...

logo
Johnny Munro 10th Sep, 2019 Insight
Brexit , Queen's Speech , Bills , Legislation
3 min read

Can MPs stop a no-deal Brexit?

“There will be opportunities for us when parliament returns in September to stop no-deal”. The words of Shadow Health Secretary Jonathan Ashworth echo what many MPs have publicly stated as they seek to advert a no-deal Brexit. Is this true? Well, that is far from certain. It is true that Parliament has plenty of options to break the resistance of a Prime Minister committed to a no-deal Brexit, including revoking Article 50, declaring no confidence in the sitting Prime Minister,...

logo
Jack Sansum 20th Aug, 2019 Insight
Brexit , Politics , UK Politics
2 min read

EU response to Johnson

Any speculation that Boris Johnson would tone down his rhetoric on his commitment to a 31 October Brexit date upon taking office has been shut down emphatically. Since his appointment last week, Johnson appointed a raft of Brexiters to his Cabinet, installed Vote Leave guru Dominic Cummings as special adviser and has hammered home his intention during every speaking opportunity. Despite this, the reality is that arithmetic in Parliament has not changed and there is little appetite for a...

logo
Joe Berkhout 7th Aug, 2019 Insight
Brexit , europe , Politics , UK Politics , EU
3 min read